To protect as many people as possible, especially the vulnerable, planning and education must begin now.
Category: healthcare
Cuomo Will Let New York Businesses Deny Customers Without Masks
“You don’t want to wear a mask, fine. Then you don’t have a right to enter that store.”
Period Poverty Is Getting Worse During Coronavirus, Warns Charity
Research has highlighted that period poverty and stigma are getting worse during the Covid-19 pandemic. Period poverty was already a major issue globally. However, due to financial strain, reduced access to products and an increase in the price of prod…
CVS Reaches Goal To Open 1,000 Coronavirus Test Sites
CVS Health Thursday said it is delivering as promised to open 1,000 testing locations for the Coronavirus strain COVID-19.
Dow Falls 150 Points After Trump Moves To Pressure China
The Dow fell for the first time in three days.
FemBeat: Tia Raises A $24 Million Series A To Scale Its Online And Offline Health Services Tailored To Women’s Needs
The fact that painkillers and Prozac have never been tested on the female physiology is but one example of the massive gender gap found in medical research.
Nuro’s Delivery Bots Adding CVS Prescriptions To Grocery And Pizza Runs
The Silicon Valley robotics company will start working with CVS Pharmacy in June in Texas.
NHS Test And Trace Personal Data ‘Will Be Kept For 20 Years’
A privacy notice provided by Public Health England (PHE), a UK government agency whose aim it is to protect the public’s health, explains that the new NHS Test and Trace system was set up to enable people with COVID-19, or those with symptoms of COVID-…
Menstrual Hygiene Day Highlights The Links Between Period Poverty & Mental Health
Created as a global advocacy platform, Menstrual Hygiene Day seeks to highlight the impact that periods and period poverty can have on people that far extends beyond their monthly bleed.
Biotech R&D Software Startup Benchling, Started By MIT Undergrads, Scores $850 Million Valuation Amid Coronavirus Pandemic
Forbes Under 30 alum Sajith Wickramasekara scores an $850 million valuation for his biotech R&D startup Benchling. Amid the coronavirus pandemic, the company is helping big biotech companies work on potential therapeutics and vaccines for Covid-19.
